LENZ
Price
$31.62
Change
-$1.78 (-5.33%)
Updated
Jul 25 closing price
Capitalization
889.98M
MBCOF
Price
$0.11
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
6.03M
Interact to see
Advertisement

LENZ vs MBCOF

Header iconLENZ vs MBCOF Comparison
Open Charts LENZ vs MBCOFBanner chart's image
LENZ Therapeutics
Price$31.62
Change-$1.78 (-5.33%)
Volume$253.18K
Capitalization889.98M
MARVEL BIOSCIENCES
Price$0.11
Change-$0.00 (-0.00%)
Volume$45K
Capitalization6.03M
LENZ vs MBCOF Comparison Chart in %
Loading...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBCOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LENZ vs. MBCOF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LENZ is a StrongBuy and MBCOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (LENZ: $31.62 vs. MBCOF: $0.11)
Brand notoriety: LENZ and MBCOF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LENZ: 88% vs. MBCOF: 180%
Market capitalization -- LENZ: $889.98M vs. MBCOF: $6.03M
LENZ [@Biotechnology] is valued at $889.98M. MBCOF’s [@Biotechnology] market capitalization is $6.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LENZ’s FA Score shows that 1 FA rating(s) are green whileMBCOF’s FA Score has 1 green FA rating(s).

  • LENZ’s FA Score: 1 green, 4 red.
  • MBCOF’s FA Score: 1 green, 4 red.
According to our system of comparison, both LENZ and MBCOF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LENZ’s TA Score shows that 3 TA indicator(s) are bullish while MBCOF’s TA Score has 3 bullish TA indicator(s).

  • LENZ’s TA Score: 3 bullish, 5 bearish.
  • MBCOF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both LENZ and MBCOF are a bad buy in the short-term.

Price Growth

LENZ (@Biotechnology) experienced а -6.26% price change this week, while MBCOF (@Biotechnology) price change was -11.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LENZ($890M) has a higher market cap than MBCOF($6.03M). MBCOF YTD gains are higher at: 60.014 vs. LENZ (9.525). LENZ has more cash in the bank: 194M vs. MBCOF (389K). LENZ has less debt than MBCOF: LENZ (1.18M) vs MBCOF (1.71M). LENZ (0) and MBCOF (0) have equivalent revenues.
LENZMBCOFLENZ / MBCOF
Capitalization890M6.03M14,750%
EBITDA-59.36MN/A-
Gain YTD9.52560.01416%
P/E Ratio47.91N/A-
Revenue00-
Total Cash194M389K49,871%
Total Debt1.18M1.71M69%
TECHNICAL ANALYSIS
Technical Analysis
LENZMBCOF
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
72%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 25 days ago
83%
Bullish Trend 14 days ago
67%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBCOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNH281.062.48
+0.89%
Unitedhealth Group
RLI67.78N/A
N/A
RLI Corp
AGFY25.43-0.11
-0.44%
Agrify Corporation
RBB18.95-0.15
-0.79%
RBB Bancorp
NWBI12.63-0.12
-0.94%
Northwest Bancshares

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
-5.33%
BEAM - LENZ
46%
Loosely correlated
+3.68%
XNCR - LENZ
46%
Loosely correlated
N/A
ZYME - LENZ
45%
Loosely correlated
-4.85%
ARWR - LENZ
45%
Loosely correlated
-3.20%
ETNB - LENZ
45%
Loosely correlated
-3.91%
More

MBCOF and

Correlation & Price change

A.I.dvisor tells us that MBCOF and IVEVF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBCOF and IVEVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBCOF
1D Price
Change %
MBCOF100%
+1.90%
IVEVF - MBCOF
32%
Poorly correlated
N/A
SLDB - MBCOF
25%
Poorly correlated
+4.79%
LENZ - MBCOF
20%
Poorly correlated
-5.33%
BSFAF - MBCOF
7%
Poorly correlated
N/A
ZEOX - MBCOF
6%
Poorly correlated
-7.59%
More